Cholestasis Due to USP53 Deficiency-Reference-Cited by-同舟云学术

Cholestasis Due to USP53 Deficiency

Published:2020-10-16 Issue:5 Volume:72 Page:667-673
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology & Nutrition
language:en
Short-container-title:

Author:

Bull Laura N.,Ellmers Rebecca,Foskett Pierre,Strautnieks Sandra,Sambrotta Melissa,Czubkowski Piotr,Jankowska Irena,Wagner Bart,Deheragoda Maesha,Thompson Richard J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology and Child Health

Reference42 articles.

1. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis;Strautnieks;Nat Genet,1998

2. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis;de Vree;Proc Natl Acad Sci U S A,1998

3. Identification and cloning of the human homolog (JAG1) of the rat Jagged1 gene from the Alagille syndrome critical region at 20p12;Oda;Genomics,1997

4. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1;Li;Nat Genet,1997

5. Mutations in DCDC2 (doublecortin domain containing protein 2) in neonatal sclerosing cholangitis;Grammatikopoulos;J Hepatol,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of the Deubiquitinase USP53: A Promising DiagnosticMarker and Therapeutic Target;Current Protein & Peptide Science;2024-11

2. Discovery and mechanism of K63-linkage-directed deubiquitinase activity in USP53;2024-07-07

3. Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials;Expert Opinion on Emerging Drugs;2024-07-04

4. What's new in pediatric genetic cholestatic liver disease: advances in etiology, diagnostics and therapeutic approaches;Current Opinion in Pediatrics;2024-06-14

5. Cholestatic Liver Disease due to Novel USP53 Mutations: A Case Series of Three Indian Children;Journal of Clinical and Experimental Hepatology;2024-03